Planetary, a Swiss bioeconomy infrastructure company, has secured €17 million ($20 million) in Series A equity and an additional €6.3 million ($7.5 million) in credit, totaling approximately €34 million ($40 million). Led by Radikal Capital and Oetker Ventures, this funding will fuel Planetary's global ingredient commercial rollout and technology licensing strategy, building on its existing operational facility in Aarberg, Switzerland, and a growing pipeline of licensing partnerships. The company has demonstrated commercial traction with its mycoprotein filet launch at ALDI Suisse and is expanding its sugar-to-protein upcycling technology globally, aiming for ultra-low-cost mycoprotein production.